Voluntary nationwide recall: Sulfamethoxazole/Trimethoprim (Amneal – June)

Jun. 2025Pharmacy Updates

Amneal Pharmaceutical LLC is recalling certain lots of Sulfamethoxazole/Trimethoprim Tablets, USP, 400 mg/80 mg. Sulfamethoxazole/Trimethoprim is used for the treatment of certain bacterial infections.

This drug is being recalled because tablets may have black spots due to microbial contamination. These black spots were reported during a product quality complaint. Using a drug that has microbial contamination may cause life-threatening illness. The use of the defective product in patients with underlying immunosuppressive conditions increases the concern for serious infections.

To see if your medication was recalled, contact your doctor or pharmacy where you received it or visit the FDA website below. If you have an affected lot of Sulfamethoxazole/Trimethoprim, you should stop using the product and return it to Amneal.

As of June 2, there had been no reports of adverse events related to this recall.

To learn more about this recall, you can take one or more of the steps below.

  • Talk to your doctor or pharmacist.
  • Call Amneal Pharmaceutical LLC at 833-582-0812. TTY users should call 711. Help is available Monday through Friday from 8 a.m. to 5 p.m. EST.
  • Visit the FDA website.

Recent Announcements

CME Webinar Series: Introducing Physicians and their teams to Value-Based Health Care

Please join us for a new CME-accredited webinar series on value-based care. This series is designed to introduce practicing physicians and their teams to value-based health care. Over the course of six sessions, we will define the components of value and identify the tools necessary to deliver high-value care for a population.
Feb. 2026Education/Webinars

Bridging Smiles and Systems: Collaborative Care for Children with Chronic Conditions

Please join us for a live, CME-accredited and CEU-accredited webinar on May 13 from noon to 1p.m., that will explore the critical connection between oral health and pediatric chronic conditions such as diabetes, asthma, congenital heart disease, and ADHD.
Feb. 2026Education/Webinars

February 2026 UPMC for You and UPMC Community HealthChoices formulary update

Pulmicort Flexhaler has a new distributor, Rubicon Holding. National Drug Codes (NDCs) for Pulmicort Flexhaler from Rubicon Holding are not included in the Medicaid Drug Rebate program and are not covered under the Medicaid Prescription Drug Program. Pulmicort Flexhaler NDCs from the previous manufacturer, H2 Pharma, have been discontinued but may be billed/dispensed until supplies are exhausted.
Feb. 2026Pharmacy Updates